Job Opportunities API

About Eucalyptus We're on a mission to make good health last a lifetime. More than 1 billion people live with obesity worldwide, driving preventable chronic conditions. We're here to build better long-term care.   Eucalyptus is now part of Hims & Hers, the global leader in personalised health and wellness.   Euc is the company behind Juniper, one of the world's largest weight-management programs combining GLP-1 medication with personalised nutrition, movement support, and clinician-led care from prescribers, nurses, health coaches, pharmacists, and dietitians. Our published clinical research shows that our combined clinical and behavioural approach helps patients lose significantly more weight during their treatment with Juniper by four times. Our Growth Story: 130% YoY revenue growth and a 90% reduction in cash burn - culminating in our $1.15bn acquisition by Hims & Hers in 2026, giving us the platform to take long-term care global Supported over 350k patients living with obesity across our 5 markets Received selective NICE endorsement to provide services to the NHS Tailored our offering to thousands of patients in Australia, the UK, Germany, Japan and Canada. About Eucalyptus We're on a mission to make good health last a lifetime. More than 1 billion people live with obesity worldwide, driving preventable chronic conditions. We're here to build better long-term care. Eucalyptus is now part of Hims & Hers, the global leader in personalised health and wellness. Euc is the company behind Juniper, one of the world's largest weight-management programs combining GLP-1 medication with personalised nutrition, movement support, and clinician-led care from prescribers, nurses, health coaches, pharmacists, and dietitians. Our published clinical research shows that our combined clinical and behavioural approach helps patients lose significantly more weight during their treatment with Juniper by four times. Our Growth Story: 130% YoY revenue growth and a 90% reduction in cash burn - culminating in our $1.15bn acquisition by Hims & Hers in 2026, giving us the platform to take long-term care global Supported over 350k patients living with obesity across our 5 markets Received selective NICE endorsement to provide services to the NHS Tailored our offering to thousands of patients in Australia, the UK, Germany, Japan and Canada About the role We have strong foundations. But to reach more markets, more brands, and more patients, we need a growth platform that gives us capabilities we don't yet have. This isn't about what to build on the surface. It's about what foundational capabilities unlock the next step change — in conversion, retention, and how fast a new market can go live. Sometimes that's personalisation. Sometimes authentication. Sometimes embedding AI into exactly the right moment in the patient journey. You'll figure that out, own the roadmap, and ship it. The roadmap doesn't exist yet — you'll define it. You'll work with a cross-functional squad of engineers and designers and: Define and own the growth platform strategy and roadmap — the foundational capabilities that unlock conversion, activation, retention, and market scalability Translate platform investments into business outcomes — every capability has a clear hypothesis for how it moves a growth metric, shipped incrementally and not after a six-month build Embed AI where it genuinely improves outcomes — identifying the moments where an intelligent layer makes the experience materially better Enable dynamic experiences across landing pages, onboarding, and in-product surfaces — the CMS, feature flagging, and content infrastructure that lets teams move without engineering dependency Build a tech stack that launches a new market in weeks, not months This is a platform role, not an infrastructure role. You care about what the platform enables for patients and growth